Funding · Pre-seed · 18 September 2026
Big Picture Bio raises £2.2m led by Kadmos Capital
London-based Big Picture Bio has raised £2.2m in a pre-seed round, led by Kadmos Capital and Exceptional Ventures. It builds a generative model that designs combination therapies for cancer. Gloucester Ventures and Innovate UK also invested. It plans to move AI-designed drug combinations from models into lab testing.
80thRound size percentile, 15 pre-seed rounds
Press report
CompanyBig Picture Bio
StagePre-seed
SectorHealthTech
Based inLondon
InvestorsKadmos Capital, Exceptional Ventures, Gloucester Ventures, Innovate UK
SourcePress · confidence highView source ↗
Your note on Big Picture Bio
Sign in to keep private notes on this company.
Is this your company?
Hide the valuation estimate straight away, add your investors, or tell us something's wrong. We check every change.